IL91423A - Preparation for the treatment of blood clots - Google Patents

Preparation for the treatment of blood clots

Info

Publication number
IL91423A
IL91423A IL9142389A IL9142389A IL91423A IL 91423 A IL91423 A IL 91423A IL 9142389 A IL9142389 A IL 9142389A IL 9142389 A IL9142389 A IL 9142389A IL 91423 A IL91423 A IL 91423A
Authority
IL
Israel
Prior art keywords
leu
ala
gin
ser
pro
Prior art date
Application number
IL9142389A
Other languages
English (en)
Hebrew (he)
Other versions
IL91423A0 (en
Original Assignee
Chugai Seiyaku Kabishiki Kaish
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Seiyaku Kabishiki Kaish filed Critical Chugai Seiyaku Kabishiki Kaish
Publication of IL91423A0 publication Critical patent/IL91423A0/xx
Publication of IL91423A publication Critical patent/IL91423A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Surgical Instruments (AREA)
  • Materials For Medical Uses (AREA)
  • Networks Using Active Elements (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IL9142389A 1988-08-24 1989-08-24 Preparation for the treatment of blood clots IL91423A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21037688 1988-08-24

Publications (2)

Publication Number Publication Date
IL91423A0 IL91423A0 (en) 1990-04-29
IL91423A true IL91423A (en) 1995-06-29

Family

ID=16588321

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9142389A IL91423A (en) 1988-08-24 1989-08-24 Preparation for the treatment of blood clots

Country Status (8)

Country Link
US (1) US5202117A (de)
EP (1) EP0355811B1 (de)
KR (1) KR950003492B1 (de)
AT (1) ATE97813T1 (de)
CA (1) CA1339071C (de)
DE (1) DE68911061T2 (de)
IL (1) IL91423A (de)
ZA (1) ZA896463B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9120304D0 (en) * 1991-09-24 1991-11-06 Erba Carlo Spa Stable pharmaceutical compositions containing a granulocyte macrophage colony stimulating factor
FR2693907B1 (fr) * 1992-07-23 1994-09-02 Rhone Poulenc Rorer Sa Procédé d'administration de solutions de facteur de stimulation des colonies granulocytaires.
US5879794A (en) * 1994-08-25 1999-03-09 W. L. Gore & Associates, Inc. Adhesive-filler film composite
DE19539574A1 (de) * 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
AU4902897A (en) 1996-11-08 1998-05-29 W.L. Gore & Associates, Inc. Method for improving reliability of thin circuit substrates by increasing the T of the substrate
KR100389726B1 (ko) * 1998-03-06 2003-06-27 쥬가이 세이야쿠 가부시키가이샤 안정한 과립구 콜로니-자극 인자 함유 제제
US8435939B2 (en) 2000-09-05 2013-05-07 Biokine Therapeutics Ltd. Polypeptide anti-HIV agent containing the same
WO2002099081A2 (en) * 2001-06-07 2002-12-12 Quark Biotech, Inc. Methods of using colony stimulating factors in the treatment of tissue damage and ischemia
EP2426139B1 (de) 2002-08-27 2014-10-01 Biokine Therapeutics Ltd. CXCR4-Antagonisten und Verwendung davon
US20090226397A1 (en) * 2003-10-24 2009-09-10 Nora Therapeutics, Inc. Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination
KR100812274B1 (ko) * 2006-10-30 2008-03-13 한양대학교 산학협력단 Ｇ-ｃｓｆ를 유효성분으로 하는 당뇨성 말초신경병 예방 및치료제
WO2008075371A2 (en) 2006-12-21 2008-06-26 Biokine Therapeutics Ltd. T-140 peptide analogs having cxcr4 super-agonist activity for immunomodulation
NZ602170A (en) 2008-02-08 2014-03-28 Ambrx Inc Modified leptin polypeptides and their uses
EA019968B1 (ru) 2008-07-23 2014-07-30 Амбркс, Инк. Модифицированные бычьи полипептиды g-csf и их применение
US9155780B2 (en) 2009-02-11 2015-10-13 Yeda Research And Development Co. Ltd. Short beta-defensin-derived peptides
US9427456B2 (en) 2009-06-14 2016-08-30 Biokine Therapeutics Ltd. Peptide therapy for increasing platelet levels
TWI480288B (zh) 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物
US9439942B2 (en) 2012-04-24 2016-09-13 Biokine Therapeutics Ltd. Peptides and use thereof in the treatment of large cell lung cancer
JP2018521983A (ja) 2015-07-16 2018-08-09 バイオカイン セラピューティックス リミテッド がんを治療するための組成物および方法
AU2017222495B2 (en) 2016-02-23 2019-08-08 Biolinerx Ltd. Methods of treating acute myeloid leukemia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766075A (en) * 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
JPS61227526A (ja) * 1984-07-25 1986-10-09 Chugai Pharmaceut Co Ltd 新規なコロニー刺激因子
AU627480B2 (en) * 1988-07-29 1992-08-27 Otsuka Pharmaceutical Co., Ltd. Il-1alpha derivatives and medicament for treating thrombocytopenia
JP2805224B2 (ja) * 1989-01-13 1998-09-30 味の素株式会社 血小板減少症治療剤

Also Published As

Publication number Publication date
EP0355811A2 (de) 1990-02-28
KR900002800A (ko) 1990-03-23
US5202117A (en) 1993-04-13
EP0355811A3 (de) 1991-03-20
IL91423A0 (en) 1990-04-29
AU4014789A (en) 1990-03-01
EP0355811B1 (de) 1993-12-01
CA1339071C (en) 1997-07-29
KR950003492B1 (ko) 1995-04-13
DE68911061T2 (de) 1994-03-24
ATE97813T1 (de) 1993-12-15
DE68911061D1 (de) 1994-01-13
AU625914B2 (en) 1992-07-16
ZA896463B (en) 1990-05-30

Similar Documents

Publication Publication Date Title
CA1339071C (en) Thrombus control agent
EP0506757B2 (de) Rekombinanter abkömmling des menschlichen faktors iii
US4552760A (en) Method for stabilizing tissue plasminogen activator and a stable aqueous solution or powder containing the same
US5112609A (en) Acidic formulations of t-PA
US4968617A (en) Solid hydrochloride salt of t-PA
EP0326014A1 (de) Zusammensetzung aus Antikoagulantia
US7070958B2 (en) Methods of making pro-urokinase mutants
CA1308377C (en) Complex of polyethyleneglycol and tissue plasminogen activator
JP2907447B2 (ja) 抗血栓剤
EP0691850B1 (de) Faktor XIII zur Behandlung von Hautwunden
EP0151996B1 (de) Verfahren zur Herstellung eines doppelkettigen Plasminogenaktivators
EP0163751B1 (de) Verfahren zur Herstellung eines Plasminogenaktivators
JP2589094B2 (ja) 抗悪性腫瘍剤
US20020151481A1 (en) MMP-2 propeptide for use as antiangiogenic or antitumor agent
JPH0369332B2 (de)
JP2697725B2 (ja) 悪性腫瘍治療用キット
EP0352897A1 (de) TPA enthaltende Arzneimittel

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees